TL;DR: Anti-aging entrepreneur Bryan Johnson says he has created a “newborn clone” of himself that could one day help grow replacement organs, test therapies, and even provide young cells for anti-ageing treatments. However, experts say the claims are highly misleading. Current science does not support the idea that a cloned human baby or a lab-grown clone could be used in the way Johnson described, and there is no evidence that he has created a viable human clone.

Bryan Johnson’s ‘Baby Clone’ Claim Sparks Debate Over the Future of Human Cloning

Tech entrepreneur and longevity advocate Bryan Johnson has made another headline-grabbing claim, saying he has “cloned” himself as a newborn as part of his mission to reverse ageing.

Johnson, whose anti-ageing regimen has attracted global attention through his Blueprint project, described the development as a glimpse into the future of medicine. According to posts on X, the alleged clone could eventually be used to test therapies, grow replacement organs, and generate young cells for regenerative treatments.

The announcement quickly sparked scepticism from scientists and physicians, many of whom argue that Johnson’s description stretches far beyond what current medical science can achieve.

What Did Bryan Johnson Claim?

In a post on X, Johnson wrote:

“I just cloned myself… as a newborn.”

He acknowledged that the idea could sound dystopian but argued that others would see it as the future of healthcare.

Johnson said the clone would initially remain in a laboratory setting and could eventually serve several purposes, including:

• Testing experimental therapies before using them on himself.
• Growing organs for transplantation.
• Developing regenerative medicine treatments.
• Producing young cells for anti-ageing therapies.
• Potentially serving as a future source for blood transfusions.

The announcement builds on Johnson’s broader mission to slow—or even reverse—the biological ageing process.

Why Is Bryan Johnson Pursuing These Experiments?

Johnson has spent millions of dollars on his Blueprint longevity programme, which combines strict nutrition, exercise, extensive medical testing, and experimental treatments aimed at improving biomarkers associated with ageing.

His unconventional health regimen has previously included:

• Daily monitoring of hundreds of biological markers.
• Intensive supplement protocols.
• Plasma exchange and blood-related therapies.
• Experimental longevity interventions supervised by physicians.

Johnson has also publicly discussed receiving plasma from his teenage son during earlier anti-ageing experiments, a practice that generated significant public debate.

More recently, Johnson revealed that he had been diagnosed with gastritis, describing the diagnosis as an opportunity to better understand the body’s repair mechanisms rather than as a setback.

Does Current Science Support Johnson’s Claims?

Most experts say no.

While regenerative medicine has made significant advances, scientists caution that Johnson’s statements combine several different technologies that are at very different stages of development.

Current research includes:

• Stem-cell therapies for certain diseases.
• Lab-grown tissues for research.
• Experimental organoids that mimic parts of human organs.
• Research into growing transplantable organs.

However, creating a cloned human capable of safely producing replacement organs remains well beyond established medical practice.

There is currently no verified evidence that Johnson has produced a viable human clone.

What Did Medical Experts Say?

Several physicians quickly challenged Johnson’s announcement.

Dr. Marc Siegel, a physician and medical commentator, argued that the technology Johnson described does not currently exist in a clinically viable form.

According to Siegel, attempts to clone mammals have historically faced major biological challenges, including developmental abnormalities and genetic instability.

He also referenced Nobel Prize-winning stem-cell research, noting that scientists are making progress with induced pluripotent stem cells (iPSCs), which can be reprogrammed to resemble embryonic stem cells. These cells are being investigated for applications such as treating Parkinson’s disease, repairing heart tissue, and restoring vision.

However, Siegel emphasized that this research should not be confused with cloning an entire human being.

His conclusion was blunt:

“He’s talking science fiction right now.”

What’s the Difference Between Cloning and Stem Cell Research?

Johnson’s announcement has also highlighted confusion surrounding several distinct areas of biotechnology.

Human cloning

Human reproductive cloning would involve creating a genetically identical human being.

No country has successfully—and publicly—produced a cloned human, and the practice is widely prohibited or heavily restricted due to ethical and scientific concerns.

Therapeutic cloning

Therapeutic cloning aims to generate cells or tissues for research or medical treatment rather than creating a human being.

This field remains experimental and is subject to strict regulation in many countries.

Stem-cell therapy

Stem-cell research seeks to repair damaged tissues or regenerate specific cell types.

Although promising, most applications remain under clinical investigation and are far more limited than Johnson’s vision of growing replacement organs on demand.

Why Johnson’s Comments Matter

Bryan Johnson has become one of the world’s most recognisable advocates for longevity science.

Because of his large online audience and willingness to publicly experiment with emerging technologies, his statements often receive significant media attention.

That visibility also places greater responsibility on accurately distinguishing between the following:

• Established medical treatments.
• Experimental research.
• Future scientific possibilities.
• Personal speculation.

Experts warn that presenting theoretical ideas as though they are already achievable can create unrealistic expectations about the current state of biotechnology.

What We Actually Know

Based on Johnson’s public statements, several facts remain unclear.

There is no publicly available scientific paper or independently verified evidence demonstrating that:

• A human clone has been created.
• A cloned embryo is being developed for organ harvesting.
• The technology Johnson describes currently exists in a clinically usable form.

Without independent verification, many of his claims should be viewed as unconfirmed assertions rather than established scientific breakthroughs.

The Bigger Picture for Longevity Research

Despite skepticism surrounding this announcement, regenerative medicine is advancing rapidly.

Researchers worldwide are actively studying:

• Stem-cell therapies.
• Artificial organs.
• 3D bioprinting of tissues.
• Gene editing.
• Cellular rejuvenation.
• Organ regeneration.

Many scientists believe these technologies could transform medicine over the coming decades. However, most caution that translating laboratory discoveries into safe treatments often takes years—or even decades—of rigorous testing.

Johnson’s latest announcement illustrates both the excitement and the controversy surrounding the rapidly evolving field of longevity science.

Key Takeaways

• Bryan Johnson claims he has created a “newborn clone” of himself to advance anti-ageing research.
• He says the technology could one day grow organs, test therapies, and provide young cells for treatment.
• Medical experts dispute the feasibility of these claims and say current science does not support them.
• Stem-cell research and regenerative medicine are progressing, but they differ significantly from human cloning.
• There is no independently verified evidence that Johnson has successfully created a cloned human.